Detalhe da pesquisa
1.
Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus.
Antimicrob Agents Chemother
; 56(2): 647-57, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21930871
2.
BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses.
J Antimicrob Chemother
; 65(1): 63-71, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19892833
3.
Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity.
J Biomed Sci
; 17: 13, 2010 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-20178582
4.
Highly enantioselective rhodium-catalyzed asymmetric 1,4-addition reactions of arylboronic acids to acyclic α,ß-unsaturated compounds: the formal synthesis of (-)-indatraline.
Chemistry
; 17(41): 11405-9, 2011 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-21882278
5.
Anti-influenza drug discovery: identification of an orally bioavailable quinoline derivative through activity- and property-guided lead optimization.
ChemMedChem
; 7(9): 1546-50, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22821876
6.
Anti-influenza drug discovery: structure-activity relationship and mechanistic insight into novel angelicin derivatives.
J Med Chem
; 53(4): 1519-33, 2010 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-20092255
7.
Synthesis and structure-activity relationships of 2-amino-1-aroylnaphthalene and 2-hydroxy-1-aroylnaphthalenes as potent antitubulin agents.
J Med Chem
; 51(24): 8163-7, 2008 Dec 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-19053773